Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.

Last year observed a global pandemic caused by SARS-CoV-2 (severe acute respiratory syndrome-coronavirus 2) infection affecting millions of individuals worldwide. There is an urgent unmet need to provide an easily producible and affordable medicine to prevent transmission and provide early treatment...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shruti Bansal, Colleen B Jonsson, Shannon L Taylor, Juan Manuel Figueroa, Andrea Vanesa Dugour, Carlos Palacios, Julio César Vega
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e05b1cc5257c495d9083045eb1033e9e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e05b1cc5257c495d9083045eb1033e9e
record_format dspace
spelling oai:doaj.org-article:e05b1cc5257c495d9083045eb1033e9e2021-12-02T20:12:37ZIota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.1932-620310.1371/journal.pone.0259943https://doaj.org/article/e05b1cc5257c495d9083045eb1033e9e2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0259943https://doaj.org/toc/1932-6203Last year observed a global pandemic caused by SARS-CoV-2 (severe acute respiratory syndrome-coronavirus 2) infection affecting millions of individuals worldwide. There is an urgent unmet need to provide an easily producible and affordable medicine to prevent transmission and provide early treatment for this disease. Since the nasal cavity and the rhinopharynx are the sites of initial replication of SARS-CoV-2, a nasal spray may be an effective option to target SARS-CoV-2 infection. In this study, we tested the antiviral action of three candidate nasal spray formulations against SARS-CoV-2 in vitro. We determined that iota-carrageenan in concentrations as low as 6 μg/mL inhibits SARS-CoV-2 in vitro. The concentrations of iota-carrageenan with activity against SARS-CoV-2 in vitro may be easily achieved through the application of nasal sprays as commonly used in several countries. Recently a double-blind, placebo-controlled study showed that iota-carrageenan in isotonic sodium chloride reduces ca. five times the risk of infection by SARS-CoV-2 in health care personnel. Further, xylitol at a concentration of 50 mg/mL (ca. 329 mM) was found to exert some antiviral action, though this preliminary finding needs further confirmation.Shruti BansalColleen B JonssonShannon L TaylorJuan Manuel FigueroaAndrea Vanesa DugourCarlos PalaciosJulio César VegaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 11, p e0259943 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Shruti Bansal
Colleen B Jonsson
Shannon L Taylor
Juan Manuel Figueroa
Andrea Vanesa Dugour
Carlos Palacios
Julio César Vega
Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.
description Last year observed a global pandemic caused by SARS-CoV-2 (severe acute respiratory syndrome-coronavirus 2) infection affecting millions of individuals worldwide. There is an urgent unmet need to provide an easily producible and affordable medicine to prevent transmission and provide early treatment for this disease. Since the nasal cavity and the rhinopharynx are the sites of initial replication of SARS-CoV-2, a nasal spray may be an effective option to target SARS-CoV-2 infection. In this study, we tested the antiviral action of three candidate nasal spray formulations against SARS-CoV-2 in vitro. We determined that iota-carrageenan in concentrations as low as 6 μg/mL inhibits SARS-CoV-2 in vitro. The concentrations of iota-carrageenan with activity against SARS-CoV-2 in vitro may be easily achieved through the application of nasal sprays as commonly used in several countries. Recently a double-blind, placebo-controlled study showed that iota-carrageenan in isotonic sodium chloride reduces ca. five times the risk of infection by SARS-CoV-2 in health care personnel. Further, xylitol at a concentration of 50 mg/mL (ca. 329 mM) was found to exert some antiviral action, though this preliminary finding needs further confirmation.
format article
author Shruti Bansal
Colleen B Jonsson
Shannon L Taylor
Juan Manuel Figueroa
Andrea Vanesa Dugour
Carlos Palacios
Julio César Vega
author_facet Shruti Bansal
Colleen B Jonsson
Shannon L Taylor
Juan Manuel Figueroa
Andrea Vanesa Dugour
Carlos Palacios
Julio César Vega
author_sort Shruti Bansal
title Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.
title_short Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.
title_full Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.
title_fullStr Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.
title_full_unstemmed Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.
title_sort iota-carrageenan and xylitol inhibit sars-cov-2 in vero cell culture.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/e05b1cc5257c495d9083045eb1033e9e
work_keys_str_mv AT shrutibansal iotacarrageenanandxylitolinhibitsarscov2inverocellculture
AT colleenbjonsson iotacarrageenanandxylitolinhibitsarscov2inverocellculture
AT shannonltaylor iotacarrageenanandxylitolinhibitsarscov2inverocellculture
AT juanmanuelfigueroa iotacarrageenanandxylitolinhibitsarscov2inverocellculture
AT andreavanesadugour iotacarrageenanandxylitolinhibitsarscov2inverocellculture
AT carlospalacios iotacarrageenanandxylitolinhibitsarscov2inverocellculture
AT juliocesarvega iotacarrageenanandxylitolinhibitsarscov2inverocellculture
_version_ 1718374915904634880